Switching to tianeptine in patients with antidepressant-induced sexual dysfunction

dc.contributor.authorAtmaca, M
dc.contributor.authorKuloglu, M
dc.contributor.authorTezcan, E
dc.contributor.authorBuyukbayram, A
dc.date.accessioned2026-08-12T17:10:42Z
dc.date.issued2003
dc.departmentFırat Üniversitesi
dc.description.abstractSexual side effects are frequent and are recently being considered as effects of antidepressant treatment. One method to improve the sexual dysfunction associated with the use of antidepressants is to change to another antidepressant. In the present work, the consequences of switching to tianeptine in patients with antidepressant-induced sexual dysfunction were studied. The study group comprised 23 patients with major depressive disorder who experienced antidepressant-induced sexual dysfunction. These antidepressants were stopped and switched to tianeptine (12.5 mg x 3/day). All patients were screened by using the clinical global impression-improvement scale (CGI-I), the Hamilton depression. rating scale (HAM-D) and the Arizona sexual experience scale (ASEX) at the beginning of the study, and at weeks 4 and 8. No patient failed to tolerate 37.5 mg of tianeptine or to complete the study except for one patient becoming pregnant. Paired t-tests revealed a significant difference between baseline and week 4 or week 8 in scores on both the HAM-D and ASEX At 8 weeks, six patients were rated as very much improved (CGI-I = 1) and ten patients were rated as much improved (CGI-I = 2). Thus, with a CGI-I score of 2 or less used to indicate a positive response, 72.7% of the patients were responders. The results suggest that switching to tianeptine appears to be useful for alleviating sexual dysfunction caused by other antidepressants. Copyright (C) 2003 John Wiley Sons, Ltd.
dc.identifier.doi10.1002/hup.479
dc.identifier.endpage280
dc.identifier.issn0885-6222
dc.identifier.issue4
dc.identifier.orcid0000-0003-2479-9139
dc.identifier.pmid12766932
dc.identifier.scopus2-s2.0-0037701632
dc.identifier.scopusqualityQ2
dc.identifier.startpage277
dc.identifier.urihttps://doi.org/10.1002/hup.479
dc.identifier.urihttps://hdl.handle.net/11508/50848
dc.identifier.volume18
dc.identifier.wosWOS:000183524400005
dc.identifier.wosqualityQ3
dc.indekslendigikaynakWeb of Science
dc.indekslendigikaynakScopus
dc.indekslendigikaynakPubMed
dc.language.isoen
dc.publisherJohn Wiley & Sons Ltd
dc.relation.ispartofHuman Psychopharmacology-Clinical and Experimental
dc.relation.publicationcategoryMakale - Uluslararası Hakemli Dergi - Kurum Öğretim Elemanı
dc.rightsinfo:eu-repo/semantics/closedAccess
dc.snmzKA_WoS_20260511
dc.subjecttianeptine
dc.subjectsexual dysfunction
dc.subjectSSRI
dc.subjectdepression
dc.subjectopen-label study
dc.titleSwitching to tianeptine in patients with antidepressant-induced sexual dysfunction
dc.typeArticle

Dosyalar